In?vivo gene editing works in humans: Results of a phase 1 clinical trial for TTR amyloidosis.
Batista AR, Flotte TR. In?vivo gene editing works in humans: Results of a phase 1 clinical trial for TTR amyloidosis. Mol Ther. 2021 09 01; 29(9):2633-2634.